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Hybrid nanosystems composed of glycogen biopolymers and gold nanoparticles were prepared by an in
situ non-toxic synthetic procedure. Transmission electron microscopy (TEM) and various spectroscopic
methods (optical absorption, X-ray photoelectron and photoluminescence spectroscopy) were used for the
characterization of the obtained bioconjugates. The gold nanoparticles formed in the presence of
glycogen were spherical in shape and approximately 15 nm in diameter. The TEM micrographs show that
the nanoparticles aggregated on the surface of the glycogen biomolecules. This effect induced a shift of
the surface plasmon resonance band towards higher wavelengths on an increase in gold ion
concentration. Effective medium theory calculations were carried out in order to explain the observed
redshift of the plasmon band in the absorption spectra of the Au–glycogen colloids. The interactions of the
gold nanoparticles with glycogen strongly affected the photoluminescence of the glycogenin protein
incorporated into its structure. The Au–glycogen hydrocolloids exhibited good chemical stability in the
presence of saline, phosphate buffered saline, alanine, histidine and D-glucose.
1 Introduction
The preparation and investigation of novel hybrid materials
composed of inorganic nanostructures and biomolecules has
evolved into a significant area of contemporary nanoscience.1–4
The increased interest in these systems is driven by a strong
demand for the development and application of novel
functional nanomaterials, especially in the fields of biotechnol-
ogy, medicine and environment protection. Among a number of
nano-biomaterials which have been reported recently, conju-
gates of biomolecules with nano-sized gold are the most
extensively studied.5 It is well known that gold nanostructures
exhibit size, shape and environment-dependent optical,6
electrical7 and photo-physical properties,8 while at the same
time they are chemically stable and nontoxic.9 The hybridiza-
tion of these nanostructures with biomolecules provides novel
functionalities, but may also lead to the appearance of
additional synergetic properties found in neither of the
constituents. Based on this approach, several gold–biomolecule
hybrids were developed and applied as contrasting agents for
the labeling and visualizing of tissues,5 drug carriers for
targeted delivery,10 the optical detection of biomolecules,11,12
or as heat sources in photothermal cancer therapy.13,14
The application of the above-mentioned systems depends
significantly on the type of biomolecule used as well as on the
morphology and arrangement of the nanoparticles. All of these
factors affect the surface plasmon resonance (SPR), the
resonant absorption and the scattering of light that occurs
due to the excitation of coherent electron oscillations at the
surface of the particle.6 For this reason, the absorption
spectrum can also provide, in combination with theoretical
models, certain information about the size, shape and
environment of the gold nanostructures. In the case of small
spherical gold nanoparticles in water, the surface plasmon
resonance occurs at approximately 525 nm, but nonspherical
nanostructures or aggregates of nanoparticles15 exhibit
absorption bands which are shifted to higher wavelengths.
On the other hand, tuning the plasmon resonance via
controlled aggregation and/or the self-assembling of nanopar-
ticles holds great promise for many practical applications.16,17
The control of the resonant absorption of the gold nanos-
tructures might also be of importance in photothermal cancer
therapy.18 It was found that the nanoparticle-induced conver-
sion of light into heat, and the consequent heat transfer to a
malignant tissue, would be facilitated by an increase in the
resonance wavelength due to the larger penetration depth of
the incident radiation. In this study, we report on the
preparation of bioconjugates, which allow the tunable
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positioning of the absorption band, that comprise gold
nanoparticles and the carbohydrate polysaccharide glycogen.
Carbohydrates, along with proteins and amino acids, are
essential components in a variety of metabolic processes. In
nanotechnology, they have applications as reducing and
templating agents for noble metal nanoparticles,19–21 while
the preparation of functional glyconanoparticles has enabled
the improved analysis of carbohydrate-based interactions with
proteins.3,22,23 Polysaccharides (starch, chitosan, alginate,
gum arabic, glycogen, etc.) are of particular interest and are
the most-studied biomolecules for this purpose. Because of
the large number of functional groups, these biopolymers have
proved to be good environments for the growth of metal,19,24–36
semiconductor27,37–39 and oxide40,41 nanoparticles. Recently,
they have been used as effective plasmonic platforms for SERS
detection and tagging,32 and catalysis.33 In addition, the
inherent biocompatibility of polysaccharides and the possibility
of using green processing methods19 in the preparation of the
nanoparticles are advantages in the medical applications of the
obtained materials.34
Glycogen is a highly branched polymer of glucose which
serves as the main glucose storage component in animal cells.
Macromolecules of this polysaccharide are spherical struc-
tures, 20–40 nm in size, which are called b-particles. The well-
defined morphology of glycogen is a consequence of the
repetitive and uniform branching and linking of 13 glucose
unit-long A-type and B-type polymer chains.42 According to the
model proposed by Melendez-Hevia and co-workers,43,44 the
structure of glycogen is optimal for the maximum glucose
storage in the smallest possible volume, the maximum portion
of the monosaccharide which can be released from the
b-particles prior to debranching, and the efficient release of
glucose. The dendrimer-like structure of glycogen also
provides a large number of functional hydroxyl groups on its
surface per volume unit of biopolymer, leading to as much as
34% of the glucose residues in the outermost layer of
glycogen.44 Due to this highly developed surface, glycogen
presents a convenient nanoreactor for the growth of metallic
nanoparticles,28 and can act as a probe material for glucan–
protein interactions.22,23 In our previous paper,28 we showed
that glycogen–Ag nanoparticle conjugates can be successfully
used as antimicrobial materials. Here we show that gold
nanoparticles interact with glycogen molecules in a completely
different way, which enables the control of the position of the
SPR band.
Glycogen is native to human hepatic cells and using this
biopolymer in biomedical applications can address the
problems of biocompatibility and toxicity which sometimes
arise in the applications of synthetic dendrimers.45
Furthermore, we used an in situ non-toxic chemical synthetic
method for the preparation of the glycogen and gold
nanoparticle hybrid nanosystems. The obtained hybrids were
investigated by microscopic, structural and optical methods.
The stability of the Au–glycogen colloids was tested in the
presence of saline, phosphate buffered saline (PBS), alanine,
histidine and D-glucose.
2 Experimental
2.1 Materials
Glycogen from bovine liver, soluble starch, gold(III) chloride
hydrate (HAuCl4?4H2O), hydrogen peroxide (H2O2), alanine
and histidine were purchased from Sigma-Aldrich and used as
received. Saline and PBS were obtained from Hemofarm,
Serbia. High purity water (specific resistance 108 V m) was
used in all of the synthetic procedures.
2.2 Synthesis of glycogen-stabilized Au nanoparticles
Gold nanoparticles were prepared in an aqueous glycogen
solution, following the reaction of HAuCl4 with H2O2, and
under the influence of ultrasonic irradiation. In a typical
procedure, 0.2 mL of a 1.56 1023 M (Au) aqueous solution of
HAuCl4?4H2O was added to 10 mL of a 0.5% glycogen solution.
The mixture was sonicated in an ultrasonic bath (Sonic, 45
kHz) for 5 min at 25 uC. After that, 0.2 mL of 1.5 6 1023 M
H2O2 was added and the solution was treated for an additional
30 min. Different samples were prepared by changing the
initial concentration of gold ions [Au] and labeled AuGly1 ([Au]
= 36 1025 M), AuGly2 ([Au] = 4.56 1025 M), AuGly3 ([Au] = 6
6 1025 M) and AuGly4 ([Au] = 9 6 1025 M). Prior to the
investigations, all of the prepared samples were aged for 24 h
under ambient conditions.
2.3 Characterization methods
The morphology of the pure glycogen particles and the Au
nanoparticles synthesized in the presence of glycogen was
investigated by transmission electron microscopy (TEM) using
a Philips CM100 instrument. The operating voltage was 80 kV.
Aqueous solutions of the Au–glycogen samples were deposited
on carbon coated copper grids and dried in air under ambient
pressure and temperature. For the investigation of the
morphology of the pure glycogen, the samples were stained
with 2% uranyl nitrate solution.
X-ray photoelectron spectroscopy (XPS) experiments were
performed on a Physical Electronics Quantum 2000 instru-
ment using Al Ka radiation (1486.6 eV). Prior to the analysis,
the samples were sputtered by a 2 keV argon ion beam. The C
1s, O 1s, and Au 4f core levels were recorded at a 29.35 eV pass
energy and a 55u take-off angle. The peak shift due to charge
accumulation was corrected using the C 1s level at 284.44 eV as
an internal standard.46 The XPS peaks were assumed to be
linear combinations of Lorentzian and Gaussian line shapes
and were resolved into individual components after the proper
subtraction of the baseline, using the Shirley background
subtraction method. The samples were prepared by the
deposition of aqueous Au–glycogen solutions on the flat
silicon wafers. They were subsequently dried in a vacuum at
40 uC.
A Nicolet 380 spectrophotometer was used for the FTIR
spectroscopic analyses of the pure glycogen and glycogen–gold
bioconjugates. The FTIR analyses were performed at room
temperature in the spectral range of 4000–400 cm21, with a
resolution of 4 cm21. The datasets were averaged over 200
scans.
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The UV-vis absorption measurements of the Au–glycogen
solutions were performed on a Thermo Evolution 600 spectro-
photometer over a wavelength range of 200–900 nm.
The photoluminescence measurements of the pure glycogen
and Au–glycogen aqueous solutions were performed on a
Perkin-Elmer LS45 fluorescence spectrophotometer. For these
analyses, we used a reference glycogen solution with the same
concentration of biopolymer and pH values as the Au–glycogen
colloids. The photoluminescence emission (PL) spectra were
recorded in the wavelength range of 330–550 nm using an
excitation wavelength lexc = 280 nm. The photoluminescence
excitation (PLE) measurements were carried out at two
emission wavelengths: lem = 360 nm and lem = 440 nm. The
spectra were recorded over 250 nm–330 nm and 250 nm–400
nm intervals, respectively. The synchronous luminescence (SL)
spectra were recorded over an excitation range of 240–500 nm
and synchronous wavelength intervals (Dl) from 30–140 nm.
All of the measurements were performed in the right angle
geometry with a scan speed of 100 nm min21 and a slit size of
10 nm.
2.4 Chemical stability of the glycogen-stabilized Au
nanoparticles
The chemical stability of the glycogen-capped Au nanoparti-
cles in the presence of saline, PBS, alanine, histidine and D-
glucose was investigated using UV-vis spectroscopy. UV-vis
absorbance spectra were recorded over a 10-day period and the
changes in the position and width of the surface plasmon
resonance bands with time were analyzed. In these analyses, 2
mL of an as-prepared 4.56 1025 M Au–glycogen solution was
mixed with 2 mL of saline (0.9% NaCl), PBS, alanine (0.2 M in
H2O), histidine (0.2 M in H2O) and D-glucose (0.1 M in H2O)
and kept under ambient conditions. PBS was prepared by
dissolving 8.0 g NaCl, 0.2 g KCl, 1.15 g Na2HPO4 and 0.2 g
KH2PO4 into 800 mL of H2O (of pH = 7.4), followed by further
addition of water to increase the volume to 1 L. The reference
sample was prepared by adding 2 mL of water into 2 mL of a
4.56 1025 M Au–glycogen solution. Each Au–glycogen system
was prepared three times, and the mean values of the surface
plasmon resonance band position and width were reported.
3 Results and discussion
3.1 Morphology and composition
The TEM analysis and particle size distribution of the pure
glycogen and the Au–glycogen samples are presented in Fig. 1.
As predicted by the glycogen models, the image of the uranyl-
stained biopolymer shows spheroidal particles of nanometer
size (Fig. 1a). The diameter of the glycogen particles ranges
from 20 to 80 nm with an average value of 45 nm and a
polydispersity of 35%. The obtained size of the particles is in
agreement with theoretical predictions for an optimal glyco-
gen particle diameter of 42 nm,43,44 as well as with reported
values of the average hydrodynamic radii for rabbit liver and
oyster glycogen particles.47 On the other hand, the particles in
Fig. 1a are larger than those observed for bovine liver glycogen
by Ryu et al.48 The TEM image of the Au–glycogen sample
obtained with an initial gold ion concentration of 3.0 6 1025
M is shown in Fig. 1b. Due to the large difference in the mass
densities of gold (19.5 g cm23) and glycogen (1 g cm23), the
metallic phase can be easily distinguished from the biopoly-
mer in the micrograph. The majority of the particles observed
were between 10 and 25 nm in size with an average diameter
Dc = 15.1 ¡ 5.4 nm. The particle size distribution in Fig. 1c
follows a log-normal dependence with parameters DLN = 13.6
nm (mean) and sLN = 0.47 (standard deviation). Fig. 1d shows
a typical TEM image of an Au–glycogen sample obtained for
[Au] = 9.0 6 1025 M. In contrast to the dispersion of the
nanoparticles observed with a low gold ion concentration, a
pronounced clustering of the nanoparticles can be seen.
However, the size of the particles does not change signifi-
cantly. The observed morphology of the sample suggests that
the gold nanoparticles are attached to the biopolymer surface,
presumably via the hydroxyl groups of A-type polymer chains
which occupy the outer layers of the glycogen particle.43
Similar morphologies to that depicted in Fig. 1d were also
observed for some of the other investigated gold ion
concentrations, as can be seen in the TEM micrographs of
the AuGly2 and AuGly3 samples (see ESI3).
X-ray photoelectron spectroscopy was used to determine the
composition and chemical environment of the elements
present in the material. An XPS survey scan (not shown)
revealed the presence of carbon, oxygen and gold core levels
(hydrogen, although present in the biomolecule, is not
detectable by XPS). Fig. 2 shows the high-resolution XPS
spectrum of the Au 4f core level of the sample prepared with
an initial Au ion concentration of 4.5 6 1025 M. Two distinct
lines separated by 3.67 eV were observed, namely the Au 4f5/2
and Au 4f7/2 lines, which occur because of the spin–orbit
Fig. 1 (a) TEM image of uranyl-stained glycogen; (b) TEM image and (c)
corresponding particle size distribution of the [Au] = 3.0 6 1025 M Au–
glycogen sample; (d) TEM image of the [Au] = 9.0 6 1025 M Au–glycogen
sample.
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splitting of the Au 4f level.49 The positions of these lines,
estimated after the correction due to charge accumulation,
were 87.91 eV and 84.24 eV, respectively. In comparison to the
reference value of bulk metallic gold of 84.04 eV49 (the vertical
line in Fig. 2), the Au 4f7/2 line was shifted towards higher
binding energies by 0.2 eV. A shift of this type was also
observed in the case of starch and polyvinyl pyrrolidone-
capped silver nanoparticles,29,30,50 and was attributed to the
cumulative effects of the adsorption of the polymer onto the
nanoparticles and the higher number of surface atoms due to
the nanoparticles’ small size.50
The interaction between the glycogen biomacromolecules
and gold nanoparticles was also investigated by FTIR spectro-
scopy, and no apparent differences were observed between the
IR spectra of the pure glycogen and glycogen–Au conjugates.
The former result implies that the biomolecule and the
nanoparticles probably interact via OH groups.19,51
3.2 Optical properties
Fig. 3a shows the UV-vis absorption spectra of aqueous
solutions of glycogen-stabilized Au nanoparticles prepared
with different initial gold ion concentrations. In the case of the
colloid with the lowest gold concentration (3.0 6 1025 M Au),
the maximum of the surface plasmon resonance band is
positioned at 526 nm. Since Mie theory52 predicts a resonant
absorption value of 525 nm for the 15 nm gold spheres in
water (refractive index n = 1.33), it can be concluded that the
position of the experimental band is unaffected by the
adsorption of the biopolymer. At higher gold concentrations,
a broadening of the bands and a shift towards higher
wavelengths was observed (Fig. 3a). The intensity of the
absorbance also increased with increasing gold content;
however, the curves presented in Fig. 3a are normalized for
clarity. The dependence of the position of the absorption
maxima (lc([Au])) on the initial gold ion concentration is
presented in Fig. 3b. The position of the band shifts linearly
with the change in [Au] according to the following equation:
lc([Au]) = 490(10) nm + 11(2)6 10
5 [Au] nm M21 (R2 = 89.8%).
This means that the presented preparation procedure offers
the possibility to tune the position of the absorption
maximum over a broad wavelength range of nearly 60 nm by
a simple change to the initial gold ion concentration.
The observed differences in the band positions in the
samples with different gold ion concentrations are a con-
sequence of the interaction of individual glycogen molecules
with multiple gold nanoparticles (see Fig. 1d). In particular,
due to the nanometer size of the glycogen particles, the
distances between the neighboring gold nanoparticles will be
sufficiently small that the dipole–dipole interactions between
them become significant. These interactions reduce the
symmetry of the absorbers (with respect to that of the isolated
spherical Au nanoparticles), which results in the appearance of
additional modes at higher wavelengths53 and, consequently,
results in the red shift of the absorption band of the colloid. At
higher gold concentrations, the average number of nanopar-
ticles per glycogen molecule increases and, due to smaller
inter-particle distances, there is a further shift of the plasmon
band towards higher wavelengths. It is worth mentioning that
in a study on gold nanoparticles stabilized with poly(amidoa-
mine) dendrimers, Srivastava et al.17 also managed to tune the
position of the plasmon resonance by controlling the distance
between the gold nanoparticles. However, instead of changing
the concentration of the gold ions as in our case, the inter-
particle distance was controlled by using different dendrimer
generations (dendrimer sizes). The observed absorption
behavior of the Au–glycogen colloids is closely related to the
Fig. 2 XPS spectrum of the Au 4f level of glycogen-stabilized gold nanoparticles
([Au] = 4.5 6 1025 M). The vertical line corresponds to the reference value for
the Au 4f7/2 level of bulk gold (84.04 eV).
Fig. 3 (a) UV-vis absorption spectra of the glycogen-stabilized gold nanoparticle
colloids; (b) the dependence of the position of the absorption maxima on the
initial gold ion concentration, and the linear fit.
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dendrimer-like structure of the glycogen b-particles and their
nanometer size. To justify the former conclusion, we have
prepared soluble starch-stabilized gold nanoparticles using
the same synthetic procedure. The molecular structure of
soluble starch is identical to that of glycogen, but its
macromolecules are predominantly linear or have a lower
extent of branching.40 In this case, it was found that the
position of the absorption bands of the Au–starch colloids was
not affected by the change in the gold ion concentration (see
Fig. S2, ESI3). The concentration-dependent optical properties
observed in Fig. 3 are also in agreement with the resonant light
scattering study of Xiang et al.22 on glycogen–gold nanopar-
ticle systems. They showed that the mixing of glycogen and a
separately-prepared gold colloid resulted in the aggregation of
the gold nanoparticles.
In order to confirm whether the proposed mechanism of
interaction of the gold nanoparticles with glycogen molecules
can indeed explain the changes in the plasmon absorption, we
performed a series of calculations based on the effective
medium theory. The employed theoretical method is based on
the approach suggested by Schatz and co-workers54 in their
investigations of the optical properties of nanoparticle
aggregates. As a starting element in the present calculations,
we considered a single glycogen molecule (represented by a
sphere of diameter 2Rg = 40 nm) covered with N gold
nanoparticles of diameter 2a = 15 nm. The dipole polarizability
aag of such an aggregate is
54
aag(l)~
eef (l){em
eef (l)z2em
Rag
3, (1)
where eef(l) is the effective dielectric function of the aggregate,
Rag = Rg + a and em = 1.78 is the dielectric constant of the
environment (the refractive index of the glycogen solution is
similar to that of water55). The polarizability a of an individual
gold nanoparticle is
a(l)~
e(l){em
e(l)z2em
a3, (2)
where e(l) is the dielectric function of the gold nanoparticles,
which can be calculated from the experimental values of gold
optical constants56 after a proper correction accounting for the
nanometer size of the particles.57 Assuming that each particle
contributes equally to the net polarizability of the aggregate,54
i.e. aag = Na, the relations (1) and (2) give
eef (l){em
eef (l)z2em
~f
e(l){em
e(l)z2em
: (3)
The value of the filling factor f represents the volume
fraction of the Au nanoparticles in the aggregate and is
represented by
f~N
a3
Rag
3
: (4)
Obviously, for given values of a and Rg, the factor f depends
solely on the number of particles N attached to the glycogen
outer layer. The values of f are limited by percolation effects,
i.e. by the maximum number of gold nanoparticles that can be
positioned on the biomolecule surface without being in
mutual contact. The experimental absorption spectra can be
qualitatively compared to the theoretically estimated absorp-
tion coefficients Aabs(l) by
Aabs(l)~
2p
l
Imeef (l)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Reeef (l)
p : (5)
By changing the values of the filling factor f, it is possible to
change the positioning of the band maxima of the Aabs(l)
curves until they match the positions of the experimental
bands. These curves and their corresponding f-values are
presented in Fig. 4. The calculations suggest that an increase
in the initial gold concentration is followed by an increase in
the filling factor. According to eqn (4), this means that, on
average, a larger number of gold particles will be attached to
each glycogen molecule. In the case of the colloid with the
lowest concentration, we found N to be 1.9, and for the highest
concentration, [Au] = 9.0 6 1025 M, N to be 8.9. A schematic
illustration of the changes in N with the change in gold
concentration is shown in the insets of Fig. 4. It should be
noted that the values of N are not absolute due to a number of
other factors that were not included in the calculations.
Fig. 4 Comparison of the experimental (black) and theoretical (red) absorption
spectra for the Au–glycogen colloids. Schematic representations of nanoparticle
aggregates are provided in the insets.
This journal is  The Royal Society of Chemistry 2013 RSC Adv., 2013, 3, 8705–8713 | 8709
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Nevertheless, the presented theoretical analysis clearly sug-
gests a possible mechanism of gold nanoparticle–glycogen
interaction which results in the red shift of the absorption
maximum. The trend of the increase in the number of
nanoparticles attached to the glycogen molecules with an
increase in [Au] is in agreement with the TEM observations
(Fig. 1).
3.3 Photoluminescence spectroscopy
To confirm the interaction between the gold nanoparticles and
glycogen, as well as to investigate the influence of the particles
on the structure of the biomolecule, we used photolumines-
cence spectroscopy. The results of this analysis for glycogen
and glycogen-stabilized gold nanoparticles ([Au] = 4.5 6 1025
M) solutions are presented in Fig. 5. The PL spectrum of the
glycogen solution (Fig. 5a), obtained at an excitation wave-
length of lexc = 280 nm, shows two broad bands positioned at
approximately 340 nm (peak A) and 426 nm (peak B). The PLE
spectra of the same sample are shown in the inset of Fig. 5a.
The spectra show that the excitation maximum for an
emission wavelength of lem = 360 nm is at 280 nm, while
two excitation peaks, at 267 nm and y360 nm, are obtained
for lem = 440 nm. The emission of glycogen, in fact, originates
from the protein glycogenin situated at the center of the
macromolecule, which acts as a primer for glycogen synth-
esis.42 Specifically, the low-wavelength band is from the
fluorescent tryptophan (lexc = 295 nm, lem = 353 nm) and
tyrosine (lexc = 275 nm, lem = 304 nm) residues,
58 while the
peak at 426 nm can be attributed to the emission from their
oxidation products.59 It is worth mentioning that although
tryptophan is a less abundant amino acid in glycogenin than
tyrosine,60 it is characterized by a larger extinction coefficient
(eTrp = 5600 M
21 cm21, eTyr = 1400 M
21 cm21), and for this
reason its emission dominates the protein fluorescence
spectrum.58 The PL spectra of the Au–glycogen solutions
(Fig. 5a) exhibit similar features as in the case of the neat
biopolymer solution. However, the presence of gold in the
system causes a decrease in the emission intensity due to the
well-known quenching effect which metal ions and surfaces
have on fluorophore emissions.61 A shift in the position of the
bands (from 340 to 364 nm for peak A and from 426 to 441 nm
for peak B) was also observed, which is a result of the change
in the local polarity around the amino acid residues.58 Since
the reduction in the intensity of the emitted light takes place
when the distances between the quenchers and the emitter are
sufficiently small62,63 the observed changes in the PL proper-
ties are also a consequence of the gold nanoparticle–glycogen
interactions discussed above.
The influence of gold on the PL emission of glycogen was
further investigated by synchronous luminescence (SL) spec-
troscopy, since SL spectra provide information regarding the
environment around the fluorophore functional groups.64 The
surface plot of the SL data of glycogen-stabilized Au
nanoparticles (concentration 4.5 6 1025 M) shows different
features to the spectrum of the glycogen solution (see Fig. S3,
ESI3). The SL spectra of glycogen and Au–glycogen solutions
obtained at scanning intervals of Dl = 70 nm and 30 nm are
shown in Fig. 5b. For these particular values of Dl, the SL
spectra reveal additional information about the effect of the
nanoparticles on the emission of the tryptophan and tyrosine
residues.64 In the Dl = 70 nm case, a decrease in intensity and
a red shift of the dominant band at lexc = 277 nm (lgm = 347
nm) in the presence of the gold nanoparticles was observed.
This band corresponds to the fluorescence of tryptophan, and
its shift towards higher wavelengths indicates that the
nanoparticles induce an increase in the polarity of the
environment around the tryptophan residues. The interaction
of the gold nanoparticles with the glycogen leads to
disaggregation of the hydrophobic cavities, thus forming a
looser glycogenin structure. Fig. 5b also shows that the
emission maximum (lem = 314 nm) from the tyrosine amino
acid (Dl = 30 nm) was not affected by the introduction of the
nanoparticles, suggesting that the polarity of the environment
around these residues did not change significantly. Similar
Fig. 5 (a) Photoluminescence emission spectra (lexc = 280 nm) of glycogen (black line) and Au–glycogen (I: 0.03 mM Au, II: 0.06 mM Au and III: 0.09 mM Au) aqueous
solutions. Photoluminescence excitation spectra (lem = 360 nm and 440 nm) of the glycogen solution are shown in the inset. (b) Synchronous photoluminescence
emission spectra of glycogen (black line) and 0.045 mM Au–glycogen (red line) solutions for Dl = 70 nm and 30 nm. The numbers in (b) correspond to the
wavelengths of the emission maxima.
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effects were observed in the case of the SL spectra of human
serum albumin treated with glycyrrhetinic acid.64 On the other
hand, Kathiravan et al. showed that the conformational
changes of bovine serum albumin induced by colloidal
AgTiO2 particles should be associated with tyrosine and not
with the tryptophan regions.65 The SL spectrum of the Au–
glycogen sample for Dl # 100 nm, characteristic for
fluorophores that produce peak B, did not show any additional
features compared to the spectrum of the glycogen solution.
3.4 Chemical stability testing
The chemical stability of the gold nanoparticle–glycogen
bioconjugates was studied by following the changes in the
position and the width of the plasmon band. The stability was
tested in environments commonly encountered in biomedical
applications such as saline, PBS, amino acids and D-glucose.
The results obtained for the AuGly2 sample are presented in
Fig. 6. The position of the plasmon band of the reference
sample (pure colloid) shifted negligibly, from 533 nm after one
day of ageing to 531 nm after 10 days, indicating the good
colloidal stability of the Au–glycogen system. It can also be
seen that the treatment with all of the tested agents did not
induce significant changes in the position of the absorption
maxima after 10 days. The width of the resonance band in the
case of the reference sample exhibited a mild increase from 59
nm after 24 h to 64 nm after 10 days. The presence of saline
solution (Fig. 6a) induced a strong variation in the plasmon
bandwidth in the early stages of testing. These changes can be
attributed to charge transfer processes occurring between the
surface of the nanoparticles and alkali ions present in the
solution.66 A similar effect was observed when the colloid was
mixed with the aromatic amino acid histidine (Fig. 6b). On the
other hand, in the presence of alanine, broadening of the
plasmon band, by approximately 5 nm, occurred. This effect is
almost independent of the ageing time and can be attributed
to the aggregation of the particles in the presence of alanine.67
Finally, there is a gradual decrease in the plasmon bandwidth
with an increase in the ageing time in the presence of D-
glucose (Fig. 6), which is probably a result of its reduction of
the residual gold ions.20
It should be noted that Kattumuri et al.25 performed a
similar procedure to test the chemical stability of the gold
nanoparticles stabilized by the polysaccharide gum arabic.
After seven days of monitoring the absorption properties of
this system in the presence of 35% saline solution, they
noticed a 15 nm red shift of the Au plasmon maximum and an
increase in the band’s width by approximately 10 nm. Also, the
mixing of the Au–gum arabic bioconjugate with a 0.2 M
histidine solution induced the broadening of the resonance
band by nearly 25 nm.25 A comparison of these results with the
results presented in Fig. 6 suggests that the stabilization of the
gold nanoparticles by glycogen molecules results in the
excellent chemical stability of the synthesized colloids.
4 Conclusion
Spherical, 15 nm diameter gold nanoparticles were synthe-
sized in the presence of the polysaccharide glycogen by an in
situ non-toxic chemical method. The experimental results on
the morphology and optical properties of the Au–glycogen
hydrocolloids, together with the theoretical analysis of the
absorption spectra, suggest that the gold nanoparticles were
attached to the surface of the glycogen particles. The
interaction of the gold nanoparticles with the biopolymer
was further confirmed by photoluminescence spectroscopy
analysis of the glycogenin protein which was incorporated into
the glycogen structure. The associations formed between the
gold nanoparticles and glycogen resulted in the good chemical
stability of the colloids in the presence of saline solutions,
amino acids and D-glucose.
The aggregation of the gold nanoparticles is related to the
glycogen morphology (nanometer size of the b-particles), and
has a profound influence on the absorption properties of these
hybrid systems. Increasing the concentration of gold ions
results in an increase in the number of nanoparticles per
glycogen molecule and consequently there is a decrease in the
distance between the nanoparticles. Since changes to the inter-
particle distance induce a shift in the plasmon band, this
Fig. 6 Changes to the gold plasmon resonance position and width, of the glycogen-stabilized gold nanoparticles, with time, in the presence of saline (black squares),
PBS (squares), 0.2 M alanine (black triangles), 0.2 M histidine (triangles) and 0.1 M D-glucose (black diamonds). The reference sample (circles) was prepared by diluting
the initial colloid solution ([Au] = 4.5 6 1025 M) with water.
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effect can be used to control the position of the maximum
absorption by changing the initial concentration of the gold
ions. The gold–glycogen nanostructures studied here could be
of interest in biomedical applications, particularly in photo-
thermal cancer therapy. The good chemical stability of this
colloidal system and the inherent biocompatibility of the
glycogen biomolecules are certainly an advantage. However,
for their successful application, further investigations are
necessary, particularly on the influence of the nanoparticle
size and loading capacity of the glycogen molecules on the
position of the absorption band, as well as on the specific
types of interaction which lead to their assembly.
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